PSY - Defiance Next Gen Altered Experience ETF ETF Analysis | Stock Taper
Logo

PSY

Defiance Next Gen Altered Experience ETF
Defiance Next Gen Altered Experience ETF
$5.90 -0.51% (-0.03)

No price data available
Asset Under Management $4.68M
Inception Date May 27, 2021
Expense Ratio 0.75%
52w High $5.92
52w Low $5.84
Volume 20,616
Asset Class Equity

About Defiance Next Gen Altered Experience ETF

The index is a rules-based index that tracks the performance of a portfolio of companies conducting legal activities under the national laws of the applicable country related to medical psychedelics, medical cannabis, cannabis pharmaceuticals and cannabidiol derivatives, and ketamine. The fund uses a “replication” strategy to achieve its investment objective, it will invest in all of the...

SECTOR HOLDINGS

Healthcare Healthcare
82.68%
Consumer Cyclical Consumer Cyclical
6.43%
Consumer Defensive Consumer Defensive
5.65%
Real Estate Real Estate
5.25%

ASSET ALLOCATION BY REGION

Other
100.00%

Holdings (Top 20)

No holdings data available.